Genprex

Tagged: cancer

Cancer And Diabetes Remain Among The Deadliest And Most Debilitating Diseases — Is Gene Therapy The Solution? One Company, Genprex, Inc. (NASDAQ: GNPX), Thinks So

Genprex Inc., a clinical-stage gene therapy company, is focused on developing for these patients with serious medical conditions and unmet need new and better treatment options that are life-changing.

Read More

Austin-based Genprex shares promising gene therapy developments for diabetes and cancer

Reprogramming the course of cancer and diabetes, Austin-based Genprex is on the cutting edge of technologies to address the biggest health concerns

Read More

Genprex CEO Commends FDA’s Initiative to Accelerate Approval Process for Gene Therapies

Genprex is advancing its novel gene therapies for large patient populations with cancer and diabetes who currently have limited treatment options

Read More

Genprex Recognizes World Cancer Day

Joins Global Movement to Raise Awareness and Reduce the Burden of Cancer Worldwide

Read More